课题基金 / 基金详情

SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE UVEORETINITIS BY NEUROPEPTIDE GENE-TRANSFECT-CELLS

SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE UVEORETINITIS BY NEUROPEPTIDE GENE-TRANSFECT-CELLS
神经肽基因转染细胞抑制实验性自身免疫性葡萄膜视网膜炎
批准号:
17591855
负责人:
KEZUKA Takeshi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

KEZUKA Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
探讨降钙素基因相关肽(CGRP)培养的成熟树突状细胞(DC)对小鼠实验性自身免疫性葡萄膜视网膜炎(EAU)的抑制作用。用GM-CSF培养C57BL/6小鼠骨髓细胞6天,用autoMACS纯化分化的CD11^+未成熟DC。将未成熟DC用LPS (1 μg/ml)培养过夜,然后在CGRP或TGF-B2存在下用人光间受体类视黄酸结合蛋白(IRBP)残基1-20 (hIRBP-p)培养。用弗氏佐剂和百日咳毒素免疫hIRBP-p诱导小鼠EAU。同时,将经hirbp -p免疫的小鼠分别静脉注射CGRP或TGF-B2培养的成熟DC。免疫后第19天测定hirbp -p特异性延迟超敏反应(DH)。免疫后第21天处死动物,病理评估EAU程度。通过注射CGRP或TGF-B2和hIRBP-p培养的成熟DC, EAU和抗原特异性DH明显受到抑制。对照组(15只EAU小鼠中13只)的发生率为87%,TGF-B2培养组(15只EAU小鼠中9只)的发生率为60%,CGRP培养组(18只EAU小鼠中5只)的发生率为28%。在接下来的实验中,我们采用电穿孔法制备了CGRP基因转染- dc。结果表明,CGRP基因转染- dc可抑制EAU,抑制IRBP-p的DH特异性。结果表明,CGRP和CGRP基因转染DC培养的成熟DC对EAU的发展具有免疫抑制作用,且比TGF-B2培养的更有效。
英文摘要
To investigate the role of the suppression in murine experimental autoimmune uveoretinitis (EAU) by mature dendritic cells (DC) cultured with calcitonin gene-related peptide (CGRP). Bone marrow cells derived from C57BL/6 mice were cultured with GM-CSF for six days, and differentiated CD11^+ immature DC were purified by autoMACS. Immature DC were further cultured with LPS (1 μg/ml) overnight, and then with human interphotoreceptor retinoid binding protein (IRBP) residues 1-20 (hIRBP-p) in the presence of CGRP or TGF-B2. EAU was induced by immunization with hIRBP-p in Freund' s adjuvant and pertussis toxin in mice. At the same time, hIRBP-p-immunized mice were injected the mature DC cultured with CGRP or TGF-B2 intravenously. On day 19 after immunization, hIRBP-p-specific delayed hypersensitivity (DH) were measured. On day 21 after immunization, animals were sacrificed, and assessed the extent of EAU pathologically. EAU and antigen-specific DH was predominantly suppressed by injection of mature DC cultured with CGRP or TGF-B2 and hIRBP-p. Incidence of EAU on control group was 87% (13 of 15 EAU mice), TGF-B2 culture group was 60% (9 of 15 EAU mice), and CGRP culture group was 28% (5 of 18 EAU mice). On the next experiments, we prepared CGRP gene-transfect-DC by electroporation methods. As the results, CGRP gene-transfect-DC can suppress EAU, and suppress DH spepific for IRBP-p. It was demonstrated that mature DC cultured with CGRP and CGRP gene-transfect-DC play an immunosuppressive role in development of EAU, which were more effective than those cultured with TGF-B2.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Possibility of inducing anterior chamber-associated immune deviation by TGF-β2 treatment of monocytes isolated from Behcets patients.
通过 TGF-β2 处理从 Behcets 患者分离的单核细胞诱导前房相关免疫偏差的可能性。
DOI: --
发表时间: 2006
期刊: Exp Eye Res 83
影响因子: --
作者: [Takeuchi M., Keino H., Suzuki J., Usui Y., Hattori T., Takeuchi A., Oh-i K., Okunuki Y., Kezuka T., Usui M.]
通讯作者: Usui M.
Intravitoreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in rats.
玻璃体内注射他克莫司 (FK506) 可抑制大鼠正在进行的实验性自身免疫性葡萄膜视网膜炎。
DOI: --
发表时间: 2007
期刊: Br J Ophthalmol 91
影响因子: --
作者: [Oh-i K., Keino H., Goto H., Yamakawa N., Murase K., Usui Y., Kezuka T., Sakai J., Takeuchi M., Usui M.]
通讯作者: Usui M.
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Kezuka T., Atherton SS.(分担執筆)]
通讯作者: Atherton SS.(分担執筆)
DOI: 10.1002/eji.200636138
发表时间: 2006-11
期刊: European Journal of Immunology
影响因子: 5.4
作者: [Y. Usui;H. Akiba;M. Takeuchi;T. Kezuka;A. Takeuchi;T. Hattori;Y. Okunuki;Tomohide Yamazaki;H. Yagita;M. Usui;K. Okumura]
通讯作者: Y. Usui;H. Akiba;M. Takeuchi;T. Kezuka;A. Takeuchi;T. Hattori;Y. Okunuki;Tomohide Yamazaki;H. Yagita;M. Usui;K. Okumura
共 9 条
    Suppression of murine experimental autoimmune optic neuritis byinnovation of mature dendritic cells transfected with calcitoningene-related peptide gene
    • 批准号:
      22591967
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2010
    • 负责人:
      KEZUKA Takeshi
    • 依托单位:
    Development of CGRP-gene-transfected immune regulatory cells for treatment of refractory uveoretinitis in human
    • 批准号:
      19592041
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2007
    • 负责人:
      KEZUKA Takeshi
    • 依托单位:
    海外基金